ID SOLUTIONS develops, produces and markets innovative in vitro diagnostic tools in the field of oncology and infectious diseases.


Founded in 2016 and ISO 13485:2016 certified, ID SOLUTIONS is located in Montpellier (France).

The company develops standardized and innovative solutions for cancer diagnosis by digital PCR from liquid biopsy samples, recovering circulating and/or FFPE tumor DNA, recovering genomic tumor DNA.

ID SOLUTIONS has also become a major contributor to the fight against COVID-19 in France by providing several RT-PCR diagnostic solutions on the market. The company offers a wide range of rapid and robust solutions, including multiplexing and typing kits for variants of interest.

We recently launched our Infectious Disease line to complement the COVID-19 line and help our customers continue to support their patients with several multiplex qPCR solutions covering various diseases around women's health or gastrointestinal diseases.


1682, rue de la Valsière, bâtiment Cap Delta

+33 4 67 79 72 60

[email protected]

Featured products


iSolutions™ HPV Fullplex qPCR

High-risk human papillomavirus viral DNA detection kit by RT-qPCR

ID™ SARS-CoV-2 / VOC Revolution Pentaplex

Real-time RT-PCR method for detection of SARS-CoV-2 RNA and screening of L452R, K417N and E484K mutations RNA


oSolutions™ EGFR 4 exons digital PCR

Most multiplexed and sensitive tool for EGFR mutation detection by 6-color Crystal Digital PCR™